NewGenIvf Group Limited Class A (NIVF)
NASDAQ: NIVFHealth CareMisc Health and Biotechnology ServicesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
NIVF stock chart
Technical analysisKey statistics
All statistics- Market cap
- $80.77K
- Forward P/E
- 0.00
- EPS (TTM)
- -$34,064.71
- Dividend yield
- None
- 52-week range
- 0.0229 – 7,257.60
- Day range
- 0.0229 – 0.0309
- Volume / Avg
- 270.77M / 6.57M
- Beta
- —
- Shares outstanding
- 2.99M
52-week range
NIVF stock today
Shares of NewGenIvf Group (NIVF) finished lower on Nov 20 at $0.0269, a drop of 23.14% or $0.0081 per share, versus the S&P 500's 3.70% decline. Volume was 41.2x the average at 270.77M shares, a sign of unusually heavy trading. Shares are 100.0% below their 52-week high of $7,257.60 and 17.5% above the 52-week low of $0.0229, near the bottom of the past year's range.
NewGenIvf Group has posted a net loss over the last twelve months (EPS of -$34,064.71), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About NewGenIvf Group
Company profileNewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also offers IVF treatment; surrogacy and ancillary caring services, and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment.
- Sector
- Health Care
- Industry
- Misc Health and Biotechnology Services
- CEO
- Mr. Wing Fung Siu
- Headquarters
- Bangkok
- Employees
- 87
- Website
- nivf.global
Financial highlights
Full financialsIn fiscal 2025, NewGenIvf Group generated $4.7 million in revenue, down 13.0% from fiscal 2024, its first annual decline since 2023. Net income was $9.9 million, for a net margin of 209.0% versus a median of 1.3% in the prior 4 years. Gross margin was 20.2% (down from 33.6%) and operating margin -226.9%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $4.73M | $5.43M | $5.14M | $5.94M | $4.12M |
| Growth | -13.01% | +5.79% | -13.59% | +44.34% | — |
| Net income | $9.88M | $-524.64K | $130.19K | $458.67K | $-533 |
| EPS (diluted) | $3.04 | $-4,408.76 | $13,019.30 | $4.72 | $0.00 |
Analyst forecast
ForecastConsensus
none
Avg. price target
$127.08+472316.36%
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
NIVF news
All NIVF newsNewGenIvf Group peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| MGRXMangoceuticals Inc. | 0.1236 | -7.55% | $2.75M | vs NIVF |
| CCELCryo-Cell International Inc. | 4.15 | 0.00% | $33.46M | vs NIVF |
| PARKPark Dental Partners Inc. | 17.03 | -6.79% | $94.26M | vs NIVF |
| VMDViemed Healthcare Inc. | 8.52 | -1.05% | $322.85M | vs NIVF |
| AGLagilon health inc. | 90.24 | +0.83% | $1.52B | vs NIVF |
| PGNYProgyny Inc. | 35.71 | +0.73% | $2.63B | vs NIVF |
| SHCSotera Health Company | 15.91 | -1.85% | $4.54B | vs NIVF |
| DVADaVita Inc. | 161.03 | +3.00% | $10.13B | vs NIVF |
Indexes, lists and sector
NewGenIvf Group stock FAQ
What is NewGenIvf Group's stock price today?
NIVF last traded at $0.0269 as of Nov 20, 4:00 PM EST, down 23.14% on the day. Prices are delayed at least 15 minutes.
Does NewGenIvf Group pay a dividend?
No. NewGenIvf Group does not currently pay a regular cash dividend.
Who is NewGenIvf Group's CEO?
Mr. Wing Fung Siu is the chief executive officer of NewGenIvf Group Limited Class A, which has about 87 employees.
Has NIVF ever split its stock?
Yes. The most recent NIVF stock split was a 1-for-8 split on Oct 23, 2026, one of 2 splits on record.
What is the NIVF 52-week high?
The 52-week high for NIVF is $7,257.60 and the 52-week low is $0.0229. The stock is currently 100.0% below its high.